MarketBeat
08 Nov 2026, 05:14 UTC · 7h ago
Perrigo Q3 Earnings Call Highlights
Impact · against what's priced in
Perrigo's outlook is negative due to lowered EPS guidance and continued sales declines driven by cautious retailer inventory and European softness. While the divestiture of the infant formula business improves the balance sheet and reduces complexity, it does not offset the immediate earnings miss and margin pressure.
- PRGO−0.30
No priced-in read yet
- In context
The company lowered its 2026 core adjusted diluted EPS guidance to $2.15-$2.35 and reported a 210bps margin contraction to 14.3%, though it announced a divestiture of its cash-consuming infant formula business to reduce its $3.3 billion debt.
Read from the article alone
